Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of single rising doses of YF476, a gastrin antagonist, in healthy male volunteers with gastro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• YF476

Snippet

Sponsor: Trio Medicines Ltd. | Conditions: Reflux Oesophagitis | Phase 1 | Status: COMPLETED